Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo/Saline
Total, all-cause mortality	5 mg/N6022
Total, all-cause mortality	10 mg/N6022
Total, all-cause mortality	20mg/N6022
Total, all-cause mortality	40 mg/N6022
Total, other adverse events	Placebo/Saline	18	19
Total, other adverse events	5 mg/N6022	9	10
Total, other adverse events	10 mg/N6022	9	9
Total, other adverse events	20mg/N6022	9	9
Total, other adverse events	40 mg/N6022	15	19
Total, serious adverse events	Placebo/Saline	1	19
Total, serious adverse events	5 mg/N6022	2	10
Total, serious adverse events	10 mg/N6022	0	9
Total, serious adverse events	20mg/N6022	0	9
Total, serious adverse events	40 mg/N6022	1	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01746784/event-totals